Clinical Study for the Comparison of Blood Insulin Pharmacokinetics in different insulin pen needles
Not Applicable
- Conditions
- Type 1 and 2 diabetes
- Registration Number
- JPRN-UMIN000004469
- Lead Sponsor
- Department of Medicine, Metabolism and Endocrinology, Juntendo University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
*Diabetic subjects, including treatment history *Subjects currently enrolled in another clinical study *Subjects who have risk in this study which is determined by a physician at the study site *Subjects who may have or may have had potentially a confusing factor in the interpretation of study results *Subjects who may be unsuitableness which is determined by a physician at the study site.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The equivalency of pharmacokinetic parameters (Cmax, Tmax, AUC0-180)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence insulin absorption through different pen needle designs in diabetes management?
How do pharmacokinetic profiles of insulin via pen needles compare to standard injection methods in type 1 and 2 diabetes?
Are there specific biomarkers that correlate with enhanced insulin delivery efficacy using pen needles in diabetic patients?
What adverse events are associated with varying insulin pen needle lengths and gauges in clinical practice?
What are the comparative effectiveness and safety of alternative insulin pen needles in managing hyperglycemia for type 1 and 2 diabetes patients?